MaaT Pharma S.A.
MAAT.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | €104 | €79 | €79 | €32 |
| - Cash | €20 | €24 | €35 | €43 |
| + Debt | €16 | €14 | €11 | €6 |
| Enterprise Value | €100 | €69 | €55 | -€5 |
| Revenue | €3 | €2 | €1 | €1 |
| % Growth | 44.3% | 55.8% | 47.1% | – |
| Gross Profit | €2 | €1 | €1 | €1 |
| % Margin | 61.1% | 35.2% | 76.3% | 82.9% |
| EBITDA | -€26 | -€22 | -€13 | -€9 |
| % Margin | -819.2% | -990.4% | -916% | -881.7% |
| Net Income | -€29 | -€20 | -€14 | -€9 |
| % Margin | -898.8% | -885% | -959% | -927.9% |
| EPS Diluted | -2.2 | -1.73 | -1.39 | -3.72 |
| % Growth | -27.2% | -24.5% | 62.6% | – |
| Operating Cash Flow | -€22 | -€19 | -€13 | -€8 |
| Capital Expenditures | -€1 | -€1 | -€1 | -€0 |
| Free Cash Flow | -€23 | -€20 | -€13 | -€8 |